Epidemiology of Hospitalized Heart Failure Differences and Similarities Between Patients with Reduced versus Preserved Ejection Fraction

被引:8
作者
Vaduganathan, Muthiah [1 ]
Fonarow, Gregg C. [2 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[2] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA 90095 USA
基金
美国医疗保健研究与质量局;
关键词
Acute heart failure; Preserved ejection fraction; Epidemiology; Outcomes; SYSTOLIC FUNCTION; SUBSEQUENT MORTALITY; NATIONAL TRENDS; OUTCOMES; RATES; REHOSPITALIZATION; PREVALENCE; ADMISSION; DEATH; STAY;
D O I
10.1016/j.hfc.2013.04.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Annually, more than 1 million patients are hospitalized for heart failure (HF), translating to high healthcare utilization and cost burden. Among patients with hospitalized HF (HHF), approximately 50% have HF with preserved ejection fraction (HFpEF) and 50% have HF with reduced ejection fraction (HFrEF), with the proportion of patients with HFpEF increasing with time. This article defines the epidemiologic landscape of patients with HHF, comparing and contrasting those with HFpEF and HFrEF, and identifies key areas that require further investigation. More complete characterization of these populations may be the first step to developing effective therapies.
引用
收藏
页码:271 / +
页数:7
相关论文
共 50 条
  • [21] Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
    Cunningham, Jonathan W.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Kulac, Ian J.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    McGrath, Martina M.
    O'Meara, Eileen
    Wilderang, Ulrica
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (14) : 1302 - 1310
  • [22] Comparison of Medication Practices in Patients With Heart Failure and Preserved Versus Those With Reduced Ejection Fraction (from the Cardiovascular Research Network [CVRN])
    Goldberg, Robert J.
    Gurwitz, Jerry H.
    Saczynski, Jane S.
    Hsu, Grace
    McManus, David D.
    Magid, David. J.
    Smith, David H.
    Go, Alan S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (09) : 1324 - 1329
  • [23] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
    Yuan, Xiao-Ye
    Ding, Cun-Tao
    Li, Jing
    Tan, Jing
    Wang, Yan-Ling
    Fan, Zhen-Xing
    He, Jing-Yu
    Yang, Wei
    Hua, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503
  • [24] Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction A Nationwide Cohort Study
    Vedin, Ola
    Lam, Carolyn S. P.
    Koh, Angela S.
    Benson, Lina
    Teng, Tiew Hwa Katherine
    Tay, Wan Ting
    Braun, Oscar O.
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Lund, Lars H.
    CIRCULATION-HEART FAILURE, 2017, 10 (06)
  • [25] Heart Failure With Preserved or Reduced Ejection Fraction in Patients Treated With Peritoneal Dialysis
    Wang, Angela Yee-Moon
    Wang, Mei
    Lam, Christopher Wai-Kei
    Chan, Iris Hiu-Shuen
    Lui, Siu-Fai
    Sanderson, John E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (06) : 975 - 983
  • [26] Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
    Vergaro, Giuseppe
    Ghionzoli, Nicolo
    Innocenti, Lisa
    Taddei, Claudia
    Giannoni, Alberto
    Valleggi, Alessandro
    Borrelli, Chiara
    Senni, Michele
    Passino, Claudio
    Emdin, Michele
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (20):
  • [27] Characteristics and Natural History of Hospitalized Heart Failure Patients With Diabetes Mellitus: Preserved versus Reduced Ejection Fraction
    Wan, Siu-Hin
    Slusser, Joshua P.
    Hodge, David O.
    Chen, Horng H.
    CIRCULATION, 2015, 132
  • [28] Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction
    Kiuchi, Shunsuke
    Hisatake, Shinji
    Kabuki, Takayuki
    Oka, Takashi
    Dobashi, Shintaro
    Fujii, Takahiro
    Ikeda, Takanori
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2020, 42 (02) : 110 - 117
  • [29] Prognosis for Patients With Heart Failure With Preserved Ejection Fraction. Is It the Same As Low Ejection Fraction?
    Doughty, Robert Neil
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (08): : 646 - 648
  • [30] Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Tromp, Jasper
    Khan, Mohsin A. F.
    Klip, IJsbrand T.
    Meyer, Sven
    de Boer, Rudolf A.
    Jaarsma, Tiny
    Hillege, Hans
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    Voors, Adriaan A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):